4.5 Article

Chemical resolution of (±)-calanolide A, (±)-cordatolide A and their 11-demethyl analogues

期刊

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 18, 期 3, 页码 1079-1083

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2007.12.008

关键词

HIV-1; chemical resolution; calanolide A; cordatolide A

向作者/读者索取更多资源

The chemical resolution of (+/-)-calanolide A and (+/-)-cordatolide A into their corresponding optically active enantiomers is described. Their inhibitory activities against HIV-1 are tested in vitro. (C) 2007 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, General & Internal

Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong

Qiaoli Peng, Runhong Zhou, Yuewen Wang, Meiqing Zhao, Na Liu, Shuang Li, Haode Huang, Dawei Yang, Ka-Kit Au, Hui Wang, Kwan Man, Kwok-Yung Yuen, Zhiwei Chen

Summary: This study compares the immunogenicity and durability of BNT162b2-mRNA and CoronaVac-inactivated vaccines in fully vaccinated individuals in Hong Kong. The results show that both vaccines induce neutralizing antibodies and spike-specific CD4 T cell responses, but CoronaVac vaccine induces lower immune responses compared to BNT162b2 vaccine. Against SARS-CoV-2 variants of concern, CoronaVac vaccine shows weaker neutralizing antibody responses compared to BNT162b2 vaccine. Three months after vaccination, neutralizing antibody levels to variants of concern decrease, along with waning memory T cell responses, especially among CoronaVac vaccine recipients.

EBIOMEDICINE (2022)

Article Multidisciplinary Sciences

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

Qian Wang, Yicheng Guo, Sho Iketani, Manoj S. Nair, Zhiteng Li, Hiroshi Mohri, Maple Wang, Jian Yu, Anthony D. Bowen, Jennifer Y. Chang, Jayesh G. Shah, Nadia Nguyen, Zhiwei Chen, Kathrine Meyers, Michael T. Yin, Magdalena E. Sobieszczyk, Zizhang Sheng, Yaoxing Huang, Lihong Liu, David D. Ho

Summary: SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 have become dominant in the United States and South Africa, raising concerns about their ability to evade neutralizing antibodies and compromise the efficacy of COVID-19 vaccines and therapeutic monoclonals. A systematic antigenic analysis reveals that BA.2.12.1 and BA.4/5 have different levels of resistance to antibodies, with BA.2.12.1 being modestly resistant and BA.4/5 being substantially resistant. Certain mutations in the spike protein facilitate antibody escape, but compromise the spike affinity for the viral receptor. Only bebtelovimab retains full potency against both subvariants.

NATURE (2022)

Article Chemistry, Medicinal

Broad-spectrum antiviral activity of Spatholobus suberectus Dunn against SARS-CoV-2, SARS-CoV-1, H5N1, and other enveloped viruses

Qingqing Liu, Ka-Yi Kwan, Tianyu Cao, Bingpeng Yan, Kumar Ganesan, Lei Jia, Feng Zhang, Chunyu Lim, Yaobin Wu, Yibin Feng, Zhiwei Chen, Li Liu, Jianping Chen

Summary: The percolation extract of Spatholobus suberectus Dunn (SSP) was found to have broad-spectrum viral entry inhibitory activity against SARS-CoV-1/2 and other enveloped viruses. In vivo studies showed no abnormal toxicity or behavior in long-term SSP treatment. These findings suggest that SSP has the potential to be developed as a drug candidate for preventing and treating COVID-19 and other emerging enveloped viruses.

PHYTOTHERAPY RESEARCH (2022)

Article Multidisciplinary Sciences

A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge

Biao Zhou, Runhong Zhou, Bingjie Tang, Jasper Fuk-Woo Chan, Mengxiao Luo, Qiaoli Peng, Shuofeng Yuan, Hang Liu, Bobo Wing-Yee Mok, Bohao Chen, Pui Wang, Vincent Kwok-Man Poon, Hin Chu, Chris Chung-Sing Chan, Jessica Oi-Ling Tsang, Chris Chun-Yiu Chan, Ka-Kit Au, Hiu-On Man, Lu Lu, Kelvin Kai-Wang To, Honglin Chen, Kwok-Yung Yuen, Shangyu Dang, Zhiwei Chen

Summary: Here, researchers successfully screened and isolated a broadly neutralizing antibody ZCB11 that can neutralize all variants of concern of SARS-CoV-2, showing particularly potent activity against the Omicron variant. Further studies demonstrated that ZCB11 predominantly interacts with the receptor-binding domain of the Omicron variant, blocking ACE2 binding. Prophylactic or therapeutic administration of ZCB11 protected against lung infection in animal models challenged with the Omicron variant.

NATURE COMMUNICATIONS (2022)

Article Gastroenterology & Hepatology

Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients

Zhiwu Tan, Mei Sum Chiu, Xinxiang Yang, Ming Yue, Tan To Cheung, Dongyan Zhou, Yuewen Wang, Anthony Wing-Hung Chan, Chi Wing Yan, Ka Yi Kwan, Yik Chun Wong, Xin Li, Jingying Zhou, Ka Fai To, Jiye Zhu, Chung Mau Lo, Alfred Sze-Lok Cheng, Stephen Lam Chan, Li Liu, You-Qiang Song, Kwan Man, Zhiwei Chen

Summary: A PD-1 isoform called Delta 42PD-1 plays an important role in the development and resistance to nivolumab immune checkpoint blockade (ICB) in hepatocellular carcinoma (HCC). We investigated the role of Delta 42PD-1 in HCC patients and found that Delta 42PD-1(+) T cells accounted for up to 71% of cytotoxic T lymphocytes in untreated HCC patients and were associated with HCC severity. These Delta 42PD-1(+) T cells were more exhausted than PD-1(+) T cells. HCC patients treated with anti-PD-1 ICB showed increased frequencies of Delta 42PD-1(+) T cells over time, especially in patients with progressive disease. Delta 42PD-1(+) T cells sustained HCC through toll-like receptor 4 signaling. An anti-Delta 42PD-1 antibody inhibited tumor growth in murine HCC models.
Article Virology

Association of human cytomegalovirus in urine with end-organ diseases in stage 2/3 HIV-1-infected individuals

Fang Zhao, Zhiwei Chen, Hui Wang, Allen Ka Loon Cheung

Summary: This study found that the presence of human cytomegalovirus (HCMV) in urine is associated with early prognosis of end-organ diseases (EODs) in patients with stage 2/3 HIV-1 infection. The detection of HCMV in urine should be implemented as a routine test.

JOURNAL OF CLINICAL VIROLOGY (2023)

Article Immunology

Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2

Mengxiao Luo, Biao Zhou, Eswar R. Reddem, Bingjie Tang, Bohao Chen, Runhong Zhou, Hang Liu, Lihong Liu, Phinikoula S. Katsamba, Ka-Kit Au, Hiu-On Man, Kelvin Kai-Wang To, Kwok-Yung Yuen, Lawrence Shapiro, Shangyu Dang, David D. Ho, Zhiwei Chen

Summary: In this study, the diversity, potency, breadth, and structural insights of bNAbs derived from memory B cells of BNT162b2-vaccinated individuals after Omicron BA.1 breakthrough infection were determined. The infection activated diverse memory B cell clonotypes that generated potent class I/II and III bNAbs with new epitopes mapped to the receptor-binding domain (RBD). While the top eight bNAbs neutralized wildtype and BA.1 effectively, they displayed different IgH/IgL sequences and neutralization profiles against other variants of concern (VOCs). Two class III NAbs, P2D9 and P3E6, showed comparable potency against BA.4/BA.5, but structural analysis revealed distinct modes of action. P3E6 neutralized all tested variants through a unique bivalent interaction with two RBDs. These findings provide new insights into the hybrid immunity generated by BNT162b2-induced diverse memory B cells in response to Omicron breakthrough infection.

EMERGING MICROBES & INFECTIONS (2023)

Article Chemistry, Multidisciplinary

Dual-Responsive Triple-Synergistic Fe-MOF for Tumor Theranostics

Zhiwei Chen, Yaoji Sun, Jiawei Wang, Xi Zhou, Xiangjian Kong, Jiashen Meng, Xingcai Zhang

Summary: The intelligent responsive drug delivery system has great potential in cancer precision therapy by intelligently releasing antitumor drugs through pH response and thermal stimulation.

ACS NANO (2023)

Article Virology

Transforming Growth Factor β Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4+ T Cells

Lok Yan Yim, Ka Shing Lam, Tsz-Yat Luk, Yufei Mo, Xiaofan Lu, Jinlin Wang, Ka-Wai Cheung, Grace Chung Yan Lui, Denise Pui Chung Chan, Bonnie Chun Kwan Wong, Thomas Tsz-Kan Lau, Chiu Bong Ngan, Dongyan Zhou, Yik Chun Wong, Zhiwu Tan, Li Liu, Hao Wu, Tong Zhang, Shui Shan Lee, Zhiwei Chen

Summary: The study reveals that plasma transforming growth factor beta (TGF-beta) is elevated during acute HIV-1 infection in men who have sex with men (MSM). TGF-beta signaling plays a crucial role in mediating HIV-1 infection of activated and resting memory CD4(+) T cells by upregulating the HIV-1 coreceptor CCR5. TGF-beta also increases CCR7 and CXCR3 expression on memory CD4(+) T cells, potentially promoting viral infection and latency establishment.

JOURNAL OF VIROLOGY (2023)

Article Multidisciplinary Sciences

An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters

Shaofeng Deng, Ying Liu, Rachel Chun-Yee Tam, Pin Chen, Anna Jinxia Zhang, Bobo Wing-Yee Mok, Teng Long, Anja Kukic, Runhong Zhou, Haoran Xu, Wenjun Song, Jasper Fuk-Woo Chan, Kelvin Kai-Wang To, Zhiwei Chen, Kwok-Yung Yuen, Pui Wang, Honglin Chen

Summary: Current available vaccines for COVID-19 are effective in reducing severe diseases and deaths caused by SARS-CoV-2 infection but less optimal in preventing infection. Next-generation vaccines which are able to induce mucosal immunity in the upper respiratory to prevent or reduce infections caused by highly transmissible variants of SARS-CoV-2 are urgently needed. We have developed an intranasal vaccine candidate based on a live attenuated influenza virus (LAIV) with a deleted NS1 gene that encodes cell surface expression of the receptor-binding-domain (RBD) of the SARS-CoV-2 spike protein, designated DelNS1-RBD4N-DAF. Immune responses and protection against virus challenge following intranasal administration of DelNS1-RBD4N-DAF vaccines were analyzed in mice and compared with intramuscular injection of the BioNTech BNT162b2 mRNA vaccine in hamsters. DelNS1-RBD4N-DAF LAIVs induced high levels of neutralizing antibodies against various SARS-CoV-2 variants in mice and hamsters and stimulated robust T cell responses in mice. Notably, vaccination with DelNS1-RBD4N-DAF LAIVs, but not BNT162b2 mRNA, prevented replication of SARS-CoV-2 variants, including Delta and Omicron BA.2, in the respiratory tissues of animals. The DelNS1-RBD4N-DAF LAIV system warrants further evaluation in humans for the control of SARS-CoV-2 transmission and, more significantly, for creating dual function vaccines against both influenza and COVID-19 for use in annual vaccination strategies.

NATURE COMMUNICATIONS (2023)

Article Engineering, Biomedical

Biodegradable Microrobots for DNA Vaccine Delivery

Shuxun Chen, Zhiwu Tan, Pan Liao, Yanfang Li, Yun Qu, Qi Zhang, Mingxuan Yang, Kannie Wai Yan Chan, Li Zhang, Kwan Man, Zhiwei Chen, Dong Sun

Summary: This study reports the fabrication of biocompatible and biodegradable GelMA microrobots through two-photon polymerization, and demonstrates programmed degradation and drug release by varying the local exposure dose. The GelMA microspheres are further functionalized for the delivery of DNA vaccines to dendritic cells and primary cells, leading to fast, enhanced, and durable antigen expression in mice.

ADVANCED HEALTHCARE MATERIALS (2023)

Editorial Material Microbiology

Editorial: AIDS 40th Year

Jiasheng Zhou, Shibo Jiang, Tongqing Zhou, Zhiwei Chen, Xia Jin, Wenyan Zhang, Supachai Rerks-ngarm, Anna Kramvis, Kai Deng, Linqi Zhang

FRONTIERS IN MICROBIOLOGY (2023)

Article Immunology

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults

Ruiqi Zhang, Kwok-Hung Chan, Pui Wang, Runhong Zhou, Henry Kwong-Chi Yau, Creany Ka-Wai Wong, Meena Wai-Lam Au, Anthony Raymond Tam, Chi-Tao Ng, Matthew Kwok-Chung Lou, Na Liu, Haode Huang, Shaofeng Deng, Rachel Chun-Yee Tam, Ying Liu, Teng Long, Hoi-Wah Tsoi, Miko K. W. Ng, Jian-Piao Cai, Kelvin Kai-Wang To, Man-Fung Yuen, Zhiwei Chen, Honglin Chen, Kwok-Yung Yuen, Ivan Fan-Ngai Hung

Summary: An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype (DelNS1-nCoV-RBD LAIV) was developed and tested for safety and immunogenicity in healthy adults. The study recruited 29 participants who were randomly assigned to receive the low or high dose vaccine or a placebo. The vaccine showed moderate mucosal immunogenicity and was well-tolerated, indicating the need for further clinical trials.

VACCINES (2023)

Article Health Care Sciences & Services

Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong

Runhong Zhou, Na Liu, Xin Li, Qiaoli Peng, Cheuk-Kwan Yiu, Haode Huang, Dawei Yang, Zhenglong Du, Hau-Yee Kwok, Ka-Kit Au, Jian-Piao Cai, Ivan Fan-Ngai Hung, Kelvin Kai -Wang To, Xiaoning Xu, Kwok-Yung Yuen, Zhiwei Chen

Summary: The ongoing outbreak of SARS-CoV-2 Omicron BA.2 infections in Hong Kong, the model city of universal masking of the world, has resulted in a major public health crisis. The timely third-dose vaccination provided significant protection with lower incidence rates of breakthrough infections. Third-dose vaccination activated spike (S)-specific memory B cells and Omicron cross-reactive T cell responses, which correlated with reduced frequencies of breakthrough infections and disease severity.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2023)

Review Immunology

Tissue-Resident Memory T Cell: Ontogenetic Cellular Mechanism and Clinical Translation

Haoran Xu, Runhong Zhou, Zhiwei Chen

Summary: This article discusses the unique role of TRM cells in immune defense, explores the cellular mechanisms underlying their development and their responsiveness in different tissue microenvironments, and emphasizes the translational potential of TRM cells and their applications in disease protection.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2023)

Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)